Ebv Positive Nasopharyngeal Carcinoma clinical trials

Explore recruiting ebv positive nasopharyngeal carcinoma clinical trials.

Recruiting ebv positive nasopharyngeal carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ebv Positive Nasopharyngeal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Ebv Positive Nasopharyngeal Carcinoma trials by city

Ebv Positive Nasopharyngeal Carcinoma in Toronto Ebv Positive Nasopharyngeal Carcinoma in Vancouver Ebv Positive Nasopharyngeal Carcinoma in Montreal Ebv Positive Nasopharyngeal Carcinoma in Calgary Ebv Positive Nasopharyngeal Carcinoma in Edmonton Ebv Positive Nasopharyngeal Carcinoma in Ottawa Ebv Positive Nasopharyngeal Carcinoma in Winnipeg Ebv Positive Nasopharyngeal Carcinoma in Quebec City Ebv Positive Nasopharyngeal Carcinoma in Hamilton Ebv Positive Nasopharyngeal Carcinoma in Kitchener Ebv Positive Nasopharyngeal Carcinoma in London Ebv Positive Nasopharyngeal Carcinoma in Halifax Ebv Positive Nasopharyngeal Carcinoma in New York Ebv Positive Nasopharyngeal Carcinoma in Los Angeles Ebv Positive Nasopharyngeal Carcinoma in Chicago Ebv Positive Nasopharyngeal Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease